1. Percutaneous Microwave Tumor Ablation Is Safe in Patients with Cardiovascular Implantable Electronic Devices: A Single-Institutional Retrospective Review
- Author
-
Fred T. Lee, Emily A. Knott, Marci L. Alexander, Timothy J. Ziemlewicz, John F. Swietlik, Katherine C. Longo, Christopher L. Brace, Meghan G. Lubner, Shane A. Wells, and J. Louis Hinshaw
- Subjects
Ablation Techniques ,Adult ,Male ,medicine.medical_specialty ,Pacemaker, Artificial ,Percutaneous ,Databases, Factual ,medicine.medical_treatment ,Risk Assessment ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Electrocardiography ,0302 clinical medicine ,Electromagnetic Fields ,Wisconsin ,Risk Factors ,Neoplasms ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,In patient ,Lead (electronics) ,Microwaves ,Aged ,Retrospective Studies ,Aged, 80 and over ,Retrospective review ,medicine.diagnostic_test ,business.industry ,Retrospective cohort study ,Interventional radiology ,Middle Aged ,Ablation ,Defibrillators, Implantable ,Tumor Burden ,Treatment Outcome ,030220 oncology & carcinogenesis ,Equipment Failure ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
The risk of electromagnetic interference between microwave (MW) ablation and cardiac implantable electronic devices (CIEDs), ie, pacemakers and defibrillators, has not been fully evaluated. Fourteen MW ablations (kidney, n = 8; liver, n = 5; lung, n = 1) were performed in 13 patients with CIEDs in normal operating mode. Electrocardiography tracings, cardiovascular complications, tumor size, tumor-to-CIED distance, and tumor-to-device lead distance were recorded. Mean tumor size was 2.9 cm, mean tumor-to-CIED distance was 26.4 cm (range, 9–30 cm), and mean tumor-to-lead distance was 12.1 cm (range, 3.5–20 cm). No device-based cardiovascular complications or class C or higher complications per Society of Interventional Radiology criteria were identified. MW ablation appears to be safe in select patients with CIEDs.
- Published
- 2018